Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients

Clinical Nephrology

Volumn 51, Issue 1, 1999, Pages 40-44

  Ahuja, T S ^a,b   Niaz, N ^a   Velasco, A ^a   Watts III, B ^a   Paar, D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Antiretroviral drugs; Hemodialysis; HIV; Plasma viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADSORPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISEASE COURSE; GENE AMPLIFICATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MORBIDITY; MORTALITY; PREDICTION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; VIRAL LOAD;

EID: 0032957340     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bingel M, Lonnemann G, Koch RM, Dinarello CA, Shaldon S 1988 Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membrane. Nephron 50: 273-276
2. Carpenter CJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA 1997 Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 277: 1962-1969
3. Deeks SG, Smith M, Holodniy M, Kalm JO 1997 HIV-1 Protease inhibitors: A review for clinicians. JAMA 222: 145-153
4. Gallicano RD, Tobe S, Sahai J, McGilveray IJ, Cameron DW, Kriger F, Garber G 1992 Pharmacokinetics of single and chronic dose zidovodine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD). J Acquir Immune Defic Syndr 5: 242-250
5. Herbelin A, Nguyen AT, Zingraff J, Urena P, DeschampsLatscha B 1990 Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor. Kidney Int 37: 116-125
6. Ifudu O, Mayers JD, Matthew JJ, Macey LJ, Brezmyak CR, McClendon E, Surgrue T, Rao TKS, Friedman EA 1997 Uremia therapy in patients end stage renal disease and human immunodeficiency virus infection: has outcome changed in the 1990s? Am J Kidney Dis 29: 549-552
7. Kimmel PI, Lew SQ, Umana WO, Li PP, Gordon AM, Straw J 1995 Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease. Blood Purif 13: 340-346
8. Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, Van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE 1996 Disposition of didanosine in HIV-seropositive patients with normal renal func-tion or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 60: 535-542
9. Mellon JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA 1996 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170
10. Ortiz C, Meneses K, Jaffe D, Fernandez JA, Perez G 1988 Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34: 248-253
11. Osborn L, Kunkel S, Nabel GJ 1989 Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of dhe nuclear factor kB. Proc Nad Acad Sci USA 86: 2336-2340
12. Pachon J, Cimeros JM, Castillo JR, Garcia PF, Canas E, Viciana P 1992 Pharmacokinetics of zidovudine in end-stage renal disease: influence of hemodialysis. AIDS 6: 827-830
13. Poignet JL, Fitting C, Delons S, Cavaillon JA 1990 Circulating interleukin-6 in long-term hemodialyzed patients. J Am Soc Nephrol (Abstract) 1: 372
14. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS 1990 Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J Exp Med 172: 151-158
15. Rao TKS, Fillippone KJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA 1984 Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673
16. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs RW, Poscher ME, Jacobsen DM, Richman DD, Valberding PA 1996 HIV viral load markers in clinical practice. Nat Med 2: 627-629
17. Winston J, Klotman PE, Klotman M 1996 Plasma HIV-1 RNA in seropositive patients with renal disease (Abstract) JASN 7: 1345